---
figid: PMC4019263__jdi-4-105-g1
figtitle: Schematic showing the mechanism‐based strategies and relationship between
  mitochondrial reactive oxygen species (ROS) and biochemical dysfunction
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC4019263
filename: jdi-4-105-g1.jpg
figlink: /pmc/articles/PMC4019263/figure/jdi12041-fig-0001/
number: F1
caption: 'Schematic showing the mechanism‐based strategies and relationship between
  mitochondrial reactive oxygen species (ROS) and biochemical dysfunction. Mitochondrial
  ROS might be a causal link between hyperglycemia and the four main metabolic dysfunctions:
  (a) activation of the polyol pathway; (b) activation of the hexosamin pathway; (c)
  activation of the protein kinase C (PKC) pathway; and (d) advanced glycation end‐products
  (AGEs) formation. In contrast, activation of the pentosephosphate pathway might
  also counter metabolic dysfunction. Mitochondria‐ targeted antioxidants or nuclear
  factor E2‐related factor 2 (Nrf2) activators might ameliorate metabolic dysfunction
  by inhibition of mitochondrial ROS or activation of transketokase, respectively.
  TCA, tricarbixylic acid cycle.'
papertitle: Mechanism‐based antioxidant therapies promise to prevent diabetic complications?.
reftext: Takeshi Nishikawa, et al. J Diabetes Investig. 2013 Mar 18;4(2):105-107.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9100714
figid_alias: PMC4019263__F1
figtype: Figure
redirect_from: /figures/PMC4019263__F1
ndex: a1f497c5-de9b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4019263__jdi-4-105-g1.html
  '@type': Dataset
  description: 'Schematic showing the mechanism‐based strategies and relationship
    between mitochondrial reactive oxygen species (ROS) and biochemical dysfunction.
    Mitochondrial ROS might be a causal link between hyperglycemia and the four main
    metabolic dysfunctions: (a) activation of the polyol pathway; (b) activation of
    the hexosamin pathway; (c) activation of the protein kinase C (PKC) pathway; and
    (d) advanced glycation end‐products (AGEs) formation. In contrast, activation
    of the pentosephosphate pathway might also counter metabolic dysfunction. Mitochondria‐
    targeted antioxidants or nuclear factor E2‐related factor 2 (Nrf2) activators
    might ameliorate metabolic dysfunction by inhibition of mitochondrial ROS or activation
    of transketokase, respectively. TCA, tricarbixylic acid cycle.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - CycE
  - cyc
  - Keap1
  - cnc
---
